Clement Denis L, Debuyzere Marc L
Department of the Dean, Ghent University Hospital, Building 3K3, 185, De Pintelaan, B-9000 Ghent, Belgium.
Curr Hypertens Rep. 2007 Jun;9(3):190-5. doi: 10.1007/s11906-007-0034-2.
The risk of peripheral artery disease is underestimated by many physicians; such risk is further augmented by the presence of hypertension. Detection of these conditions is essential to prevent cardiovascular accidents. This review deals with the management of peripheral artery disease as a risk factor, highlighting the need for triple therapy (antiplatelet drugs, angiotensin-converting enzyme inhibitors, and statins). Treatment of hypertension is approached by reviewing the essentials of the different antihypertensive drugs available, focusing on their peripheral circulatory effect. However, because individual antihypertensive drugs seem not to differ largely in this respect, attention is drawn to the message that the most important task in these patients is to control total cardiovascular risk rather than focusing on the choice of the individual antihypertensive drug.
许多医生低估了外周动脉疾病的风险;高血压的存在会进一步增加这种风险。检测这些病症对于预防心血管意外至关重要。本综述探讨了将外周动脉疾病作为一种风险因素的管理方法,强调了三联疗法(抗血小板药物、血管紧张素转换酶抑制剂和他汀类药物)的必要性。通过回顾现有不同抗高血压药物的要点来探讨高血压的治疗,重点关注它们对外周循环的影响。然而,由于个体抗高血压药物在这方面似乎没有很大差异,因此提请注意这样一个信息,即这些患者最重要的任务是控制总体心血管风险,而不是专注于个体抗高血压药物的选择。